» Articles » PMID: 15775727

Medication Use During Pregnancy and Lactation: an Urgent Call for Public Health Action

Overview
Date 2005 Mar 19
PMID 15775727
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Questions about medication use during pregnancy and lactation are a concern for women and healthcare providers. Unfortunately, there is little experience with the use of most medications in human pregnancy and lactation at the time they are marketed. Even when information is available, it may not be readily accessible to women and healthcare providers. Nevertheless, medication use by pregnant and breastfeeding women may be beneficial, and even essential, to ensure the health of both mother and child. In addition, almost half of pregnancies in the United States each year are unintended, and medication exposures may occur in the early weeks of gestation before a pregnancy is recognized. For these reasons, it is critical that up-to-date information about the effects of medication use during pregnancy and lactation and the management of maternal conditions be available to women and healthcare providers. A comprehensive, coordinated public health approach that builds on and expands existing activities is needed to generate information about medication use, make that information readily available, and translate it into safe and effective healthcare. Critical components of this system include a central source of up-to-date information, further development and coordination of monitoring and research activities, the availability of counseling services throughout the country, development of standard communication messages, and a panel of experts to provide oversight. This will require collaborative support from government agencies, nonprofit organizations, academic and public health professionals, and healthcare providers to ensure safe and beneficial use of medications during pregnancy and lactation.

Citing Articles

Insights and perceptions: Investigating pregnant women's attitudes, understanding, and factors influencing knowledge regarding medication usage during pregnancy-A cross-sectional study.

Al-Khawlani A, Qasim Q, Halboup A, Thiab S, Zawiah M, Al-Ashwal F PLoS One. 2024; 19(10):e0311235.

PMID: 39352911 PMC: 11444415. DOI: 10.1371/journal.pone.0311235.


Obstetrician-Gynecologist Views of Pregnancy-Related Medication Safety.

SteelFisher G, Hero J, Caporello H, Blendon R, Walker W, Broussard C J Womens Health (Larchmt). 2020; 29(8):1113-1121.

PMID: 32233962 PMC: 10614027. DOI: 10.1089/jwh.2019.8007.


Self-medication and knowledge among pregnant women attending primary healthcare services in Malang, Indonesia: a cross-sectional study.

Atmadani R, Nkoka O, Yunita S, Chen Y BMC Pregnancy Childbirth. 2020; 20(1):42.

PMID: 31948428 PMC: 6966862. DOI: 10.1186/s12884-020-2736-2.


Prevalence and maternal characteristics associated with receipt of prenatal care provider counseling about medications safe to take during pregnancy.

DAngelo D, Bauman B, Broussard C, Tong V, Ko J, Kapaya M Prev Med. 2019; 126:105743.

PMID: 31173804 PMC: 10985656. DOI: 10.1016/j.ypmed.2019.06.001.


Safety Profile of Drug Use During Pregnancy at Peripheral Health Centres in Burkina Faso: A Prospective Observational Cohort Study.

Rouamba T, Valea I, Bognini J, Kpoda H, F Mens P, Gomes M Drugs Real World Outcomes. 2018; 5(3):193-206.

PMID: 30155832 PMC: 6119166. DOI: 10.1007/s40801-018-0141-1.